newsfilter
← Latest News
Business Wire·

Dicerna to Report First Quarter 2021 Financial Results on May 6, 2021

Dicerna Pharmaceuticals, Inc. (NASDAQ:DRNA) (the "Company" or "Dicerna"), a leading developer of investigational ribonucleic acid interference (RNAi) therapeutics, today announced that the Company will release its first quarter 2021 financial results af